{"content":"<li class=\"n-box-item date-title\" data-end=\"1356152399\" data-start=\"1356066000\" data-txt=\"Wednesday, December 18, 2019\">Friday, December 21, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"733861\" data-ts=\"1356136010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXA\" target=\"_blank\">ALXA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The FDA&#39;s approval of Alexza Pharmaceutical&#39;s (NASDAQ:ALXA) Adasuve comes with several...</a></h4><p>The FDA's <a href=\"https://seekingalpha.com/market_currents/post/733471\" target=\"_blank\">approval</a> of Alexza Pharmaceutical's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALXA\" title=\"Alexza Pharmaceuticals, Inc.\">ALXA</a>) Adasuve comes with <a href=\"http://www.theflyonthewall.com/permalinks/entry.php/ALXAid1759696/ALXA-Alexzas-Adasuve-FDA-approval-has-several-post-approval-requirements\" target=\"_blank\">several post-approval requirements</a>, including a large observational clinical trial to gather patient safety data based on real-world use, as well as a clinical program addressing the safety and efficacy of the drug adolescent patients. Shares <font color=\"red\">-11%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"733861\" data-linked=\"The FDA&#39;s approval of Alexza Pharmaceutical&#39;s (NASDAQ:ALXA) Adasuve comes with several...\" data-tweet=\"$ALXA - The FDA&#39;s approval of Alexza Pharmaceutical&#39;s (NASDAQ:ALXA) Adasuve comes with several post-approval requirements, including a large observational clinical trial to gather patient safety data based on real-world use, as well as a clinical progra... https://seekingalpha.com/news/733861?source=tweet\" data-url=\"https://seekingalpha.com/news/733861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733731\" data-ts=\"1356129511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TFSL\" target=\"_blank\">TFSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: TFSL +6%. PACT +3%. PBRA +3%. DANG +3%. OIBRC +2%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/TFSL' title='TFS Financial Corporation'>TFSL</a> <font color=\"green\">+6%</font>. <a href='https://seekingalpha.com/symbol/PACT' title='Pactera Technology International Ltd.'>PACT</a> <font color=\"green\">+3%</font>. PBRA <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/DANG' title='E-Commerce China Dangdang Inc.'>DANG</a> <font color=\"green\">+3%</font>. OIBRC <font color=\"green\">+2%</font>.  <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/ALXA' title='Alexza Pharmaceuticals, Inc.'>ALXA</a> <font color=\"red\">-13.13%</font>. <a href='https://seekingalpha.com/symbol/PATH' title=''>PATH</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/TXT' title='Textron Inc'>TXT</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/NSU' title='Nevsun Resources Ltd.'>NSU</a> <font color=\"red\">-4%</font>.<div class=\"tiny-share-widget\" data-id=\"733731\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: TFSL +6%. PACT +3%. PBRA +3%. DANG +3%. OIBRC +2%....\" data-tweet=\"$TFSL $TFSL $PACT - After-hours top gainers, as of 5:15 p.m.: TFSL +6%. PACT +3%. PBRA +3%. DANG +3%. OIBRC +2%. After-hours top losers: ALXA -13.13%. PATH -7%. SVU -4%. TXT -4%. NSU -4%. https://seekingalpha.com/news/733731?source=tweet\" data-url=\"https://seekingalpha.com/news/733731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733571\" data-ts=\"1356124552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OIIM\" target=\"_blank\">OIIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">O2Micro (NASDAQ:OIIM) warns it expects Q4 revenue of $16M-$17M, below prior guidance of...</a></h4><p>O2Micro (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OIIM\" title=\"O2Micro International Limited\">OIIM</a>) warns it expects Q4 revenue of $16M-$17M, below prior guidance of $17M-$20M and a consensus of $18.6M. The company, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/569771\">no stranger</a> to warnings, blames \"broad-based weakness in demand in our end markets, coupled with lower than normal inventories being held in the supply chain.\" At least a few other chipmakers have <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/699921\">similar problems</a>. Shares are likely to fall after <font color=\"green\">rising 8%</font> in regular trading. (PR)</p><div class=\"tiny-share-widget\" data-id=\"733571\" data-linked=\"O2Micro (NASDAQ:OIIM) warns it expects Q4 revenue of $16M-$17M, below prior guidance of...\" data-tweet=\"$OIIM $SOXX $SMH - O2Micro (NASDAQ:OIIM) warns it expects Q4 revenue of $16M-$17M, below prior guidance of $17M-$20M and a consensus of $18.6M. The company, no stranger to warnings, blames &quot;broad-based weakness in demand in our end markets, coupled with... https://seekingalpha.com/news/733571?source=tweet\" data-url=\"https://seekingalpha.com/news/733571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733561\" data-ts=\"1356124297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Herbalife (HLF -19.9%) get slammed again today on heavy volume as Bill Ackman&#39;s...</a></h4><p>Shares of Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"red\">-19.9%</font>) get slammed again today on heavy volume as Bill Ackman's Pershing Square <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/732541\">continues its assault</a> on the company, underlining its massive short position and encapsulating yesterdays meeting in presentation format on its website: (<a target=\"_blank\" href=\"http://factsaboutherbalife.com/\">Facts About Herbalife</a>)</p><div class=\"tiny-share-widget\" data-id=\"733561\" data-linked=\"Shares of Herbalife (HLF -19.9%) get slammed again today on heavy volume as Bill Ackman&#39;s...\" data-tweet=\"$HLF - Shares of Herbalife (HLF -19.9%) get slammed again today on heavy volume as Bill Ackman&#39;s Pershing Square continues its assault on the company, underlining its massive short position and encapsulating yesterdays meeting in presentation format on ... https://seekingalpha.com/news/733561?source=tweet\" data-url=\"https://seekingalpha.com/news/733561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733511\" data-ts=\"1356123846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEB\" target=\"_blank\">HEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733511\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hemispherx Biopharma (HEB -21.2%) gets slammed today after saying the FDA&#39;s Arthritis Advisory...</a></h4>Hemispherx Biopharma (<a href='https://seekingalpha.com/symbol/HEB' title='Hemispherx Biopharma, Inc'>HEB</a> <font color=\"red\">-21.2%</font>) gets slammed today after saying the FDA's Arthritis Advisory Committee has <a href=\"http://www.streetinsider.com/Corporate+News/Hemispherx+%28HEB%29+Updates+on+FDA+Panel+Vote+for+Ampligen%3B+Fails+to+Win+Backing/7967322.html\" target=\"_blank\">shot down</a> its New Drug Application for the marketing of Ampligen for chronic fatigue syndrome by a 9-4 vote, with one abstention. The agency said that, considering the totality of the data, there wasn't sufficient evidence of Ampligen's safety or treatment efficacy.<div class=\"tiny-share-widget\" data-id=\"733511\" data-linked=\"Hemispherx Biopharma (HEB -21.2%) gets slammed today after saying the FDA&#39;s Arthritis Advisory...\" data-tweet=\"$HEB $AIM - Hemispherx Biopharma (HEB -21.2%) gets slammed today after saying the FDA&#39;s Arthritis Advisory Committee has shot down its New Drug Application for the marketing of Ampligen for chronic fatigue syndrome by a 9-4 vote, with one abstention. Th... https://seekingalpha.com/news/733511?source=tweet\" data-url=\"https://seekingalpha.com/news/733511\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733491\" data-ts=\"1356123035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALJ\" target=\"_blank\">ALJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Alon USA Energy (ALJ +9.3%) break out to a multi-year high on no apparent news,...</a></h4><p>Shares of Alon USA Energy (<a href=\"https://seekingalpha.com/symbol/ALJ\" title=\"Alon USA Energy, Inc.\">ALJ</a> <font color=\"green\">+9.3%</font>) break out to a multi-year high on no apparent news, although it is said the company may be on the verge of paying a <a target=\"_blank\" href=\"http://www.smallcapnetwork.com/Putting-the-Pedal-to-the-Metal-ALXA-SPPI-and-ALJ-Poked-and-Prodded/s/via/10/article/view/p/mid/1/id/200/\">big cash dividend</a> following the IPO of its MLP Alon USA Partners (<a href=\"https://seekingalpha.com/symbol/ALDW\" title=\"Alon USA Partners\">ALDW</a> <font color=\"green\">+1.2%</font>).</p><div class=\"tiny-share-widget\" data-id=\"733491\" data-linked=\"Shares of Alon USA Energy (ALJ +9.3%) break out to a multi-year high on no apparent news,...\" data-tweet=\"$ALJ $ALJ $ALDW - Shares of Alon USA Energy (ALJ +9.3%) break out to a multi-year high on no apparent news, although it is said the company may be on the verge of paying a big cash dividend following the IPO of its MLP Alon USA Partners (ALDW +1.2%). https://seekingalpha.com/news/733491?source=tweet\" data-url=\"https://seekingalpha.com/news/733491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733451\" data-ts=\"1356121478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDT\" target=\"_blank\">MDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The FDA says it recalled Medtronic&#39;s (MDT -1.4%) SynchroMed II and SynchroMed EL implantable...</a></h4><p>The FDA says <a href=\"http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm333231.htm\" target=\"_blank\">it recalled</a> Medtronic's (<a href=\"https://seekingalpha.com/symbol/MDT\" title=\"Medtronic plc\">MDT</a> <font color=\"red\">-1.4%</font>) SynchroMed II and SynchroMed EL implantable drug infusion pumps back in November, saying that the use of unapproved drugs can lead to \"intermittent or permanent pump motor stall and cessation of drug infusion.\" The overall failure rate of the SynchroMed II pump at 78 months post implant is 2.4% when used to dispense approved drugs, but it climbs to 7.0% when used to dispense unapproved drugs.</p><div class=\"tiny-share-widget\" data-id=\"733451\" data-linked=\"The FDA says it recalled Medtronic&#39;s (MDT -1.4%) SynchroMed II and SynchroMed EL implantable...\" data-tweet=\"$MDT - The FDA says it recalled Medtronic&#39;s (MDT -1.4%) SynchroMed II and SynchroMed EL implantable drug infusion pumps back in November, saying that the use of unapproved drugs can lead to &quot;intermittent or permanent pump motor stall and cessation of dr... https://seekingalpha.com/news/733451?source=tweet\" data-url=\"https://seekingalpha.com/news/733451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733431\" data-ts=\"1356120329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDI\" target=\"_blank\">GDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gardner Denver (GDI -10.3%) reportedly ends deal talks with SPX (SPW +1.3%) and invites PE firms...</a></h4>Gardner Denver (<a href='https://seekingalpha.com/symbol/GDI' title='Gardner Denver Holdings, Inc.'>GDI</a> <font color=\"red\">-10.3%</font>) reportedly <a target=\"_blank\" href=\"http://in.reuters.com/article/2012/12/21/us-gardnerdenver-spx-idINBRE8BK12620121221\">ends deal talks</a> with SPX (SPW <font color=\"green\">+1.3%</font>) and invites PE firms that made earlier offers for the industrial machinery maker to meet with management in early January. The talks between GDI and SPX were said to have focused on an <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=gdi+spx\">SPX offer</a> of ~$85/share, but ended after doubts emerged on both sides about the deal's success.<div class=\"tiny-share-widget\" data-id=\"733431\" data-linked=\"Gardner Denver (GDI -10.3%) reportedly ends deal talks with SPX (SPW +1.3%) and invites PE firms...\" data-tweet=\"$GDI $GDI $SPXC - Gardner Denver (GDI -10.3%) reportedly ends deal talks with SPX (SPW +1.3%) and invites PE firms that made earlier offers for the industrial machinery maker to meet with management in early January. The talks between GDI and SPX were s... https://seekingalpha.com/news/733431?source=tweet\" data-url=\"https://seekingalpha.com/news/733431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733401\" data-ts=\"1356119562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XEC\" target=\"_blank\">XEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733401\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cimarex Energy (XEC -0.1%) is initiated with a Buy rating at Global Hunter, which highlights...</a></h4>Cimarex Energy (<a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a> <font color=\"red\">-0.1%</font>) is initiated with a <a href=\"http://www.streetinsider.com/New+Coverage/Global+Hunter+Securities+Starts+Cimarex+Energy+%28XEC%29+at+Buy%2C+%2477+PT/7966091.html\" target=\"_blank\">Buy rating</a> at Global Hunter, which highlights XEC's diversified asset base, conservative balance sheet and substantial cash  flow which allow for the flexibility to move capital to the areas of  highest returns such as the Permian Basin. The firm \"conservatively  estimate[s]\" XEC may have more than 860 future drilling locations in its core areas.<div class=\"tiny-share-widget\" data-id=\"733401\" data-linked=\"Cimarex Energy (XEC -0.1%) is initiated with a Buy rating at Global Hunter, which highlights...\" data-tweet=\"$XEC - Cimarex Energy (XEC -0.1%) is initiated with a Buy rating at Global Hunter, which highlights XEC&#39;s diversified asset base, conservative balance sheet and substantial cash flow which allow for the flexibility to move capital to the areas of highes... https://seekingalpha.com/news/733401?source=tweet\" data-url=\"https://seekingalpha.com/news/733401\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733381\" data-ts=\"1356118513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLR\" target=\"_blank\">OCLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oclaro (OCLR -7.1%) is having a bad day after providing details about its recently-closed...</a></h4><p>Oclaro (<a href=\"https://seekingalpha.com/symbol/OCLR\" title=\"Oclaro, Inc.\">OCLR</a> <font color=\"red\">-7.1%</font>) is having a bad day after <a href=\"http://biz.yahoo.com/e/121220/oclr8-k.html\" target=\"_blank\">providing details</a> about its recently-closed <a href=\"https://seekingalpha.com/currents/post/713151\" target=\"_blank\">offering</a> of 7.5% convertible notes due 2018. The notes are accompanied by an indenture that limits Oclaro's ability to raise more debt, pay dividends, redeem junior debt, or buy back stock, among other things, and place major restrictions on Oclaro's ability to redeem the notes before they come due.</p><div class=\"tiny-share-widget\" data-id=\"733381\" data-linked=\"Oclaro (OCLR -7.1%) is having a bad day after providing details about its recently-closed...\" data-tweet=\"$OCLR - Oclaro (OCLR -7.1%) is having a bad day after providing details about its recently-closed offering of 7.5% convertible notes due 2018. The notes are accompanied by an indenture that limits Oclaro&#39;s ability to raise more debt, pay dividends, rede... https://seekingalpha.com/news/733381?source=tweet\" data-url=\"https://seekingalpha.com/news/733381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733331\" data-ts=\"1356117497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZNP\" target=\"_blank\">HZNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733331\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon Pharma (HZNP -1.8%) receives a marketing authorization from the UK Medicines and...</a></h4><p>Horizon Pharma (<a href=\"https://seekingalpha.com/symbol/HZNP\" title=\"Horizon Pharma plc\">HZNP</a> <font color=\"red\">-1.8%</font>) receives a marketing authorization from the UK Medicines and Healthcare products Regulatory Agency for Duexis, for the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis  and to decrease the risk of developing upper gastrointestinal ulcers. The authorization stemmed from the favorable recommendation coming out of the Commission on Human Medicines.</p><div class=\"tiny-share-widget\" data-id=\"733331\" data-linked=\"Horizon Pharma (HZNP -1.8%) receives a marketing authorization from the UK Medicines and...\" data-tweet=\"$HZNP - Horizon Pharma (HZNP -1.8%) receives a marketing authorization from the UK Medicines and Healthcare products Regulatory Agency for Duexis, for the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the r... https://seekingalpha.com/news/733331?source=tweet\" data-url=\"https://seekingalpha.com/news/733331\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733321\" data-ts=\"1356116944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RIM (RIMM -21.2%) has added to its losses, as worries about the impact of BB10&#39;s services...</a></h4><p>RIM (RIMM <font color=\"red\">-21.2%</font>) has added to its losses, as <a href=\"https://seekingalpha.com/currents/post/732551\" target=\"_blank\">worries</a> about the impact of BB10's services pricing mount. <a href=\"http://www.streetinsider.com/Analyst+Comments/RIM+%28RIMM%29+Service+Revenue+Will+Decline%2C+Not+Disappear+Stresses+Goldman/7966689.html\" target=\"_blank\">Goldman</a>, which upgraded RIM to Buy last month (<a href=\"https://seekingalpha.com/currents/post/689991\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/691181\" target=\"_blank\">II</a>), suggests investors are overreacting, since BB7 won't be affected. But <a href=\"http://www.streetinsider.com/Earnings/RIM+%28RIMM%29+Put+Through+the+Shredder+on+Service+Revenue+Worries/7966866.html\" target=\"_blank\">Deutsche</a> is less sanguine, forecasting RIM's service revenue will fall 20% each of the next 2 years. Ditto <a href=\"http://blogs.barrons.com/techtraderdaily/2012/12/21/rimm-clsa-cuts-to-sell-faustian-bargain-in-yielding-services-revenue/?mod=BOLBlog&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+barrons%2Ftechtraderdaily%2Ffeed+%28BARRONS.com+Blog%3A+Tech+Trader+Daily%29\" target=\"_blank\">CLSA</a>, which is \"downgrading\" shares to Sell from Underperform. \"RIMM\u2019s business model is being challenged by operators that are unwilling to both subsidize devices aggressively and hand over a slice of their data revenue.\" (<a href=\"https://seekingalpha.com/article/1076641-research-in-motion-limited-management-discusses-q3-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>)</p><div class=\"tiny-share-widget\" data-id=\"733321\" data-linked=\"RIM (RIMM -21.2%) has added to its losses, as worries about the impact of BB10&#39;s services...\" data-tweet=\"$BB - RIM (RIMM -21.2%) has added to its losses, as worries about the impact of BB10&#39;s services pricing mount. Goldman, which upgraded RIM to Buy last month (I, II), suggests investors are overreacting, since BB7 won&#39;t be affected. But Deutsche is less ... https://seekingalpha.com/news/733321?source=tweet\" data-url=\"https://seekingalpha.com/news/733321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733291\" data-ts=\"1356115626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733291\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coronado Biosciences (CNDO -5.9%) says it&#39;s signed a clinical trial agreement with the National...</a></h4><p>Coronado Biosciences (CNDO <font color=\"red\">-5.9%</font>) says it's signed a clinical trial agreement with the National Institute of Allergy and Infectious Diseases to evaluate its experimental Trichuris suis ova, or CNDO-201, for the treatment of ulcerative colitis. The multi-center study will examine the safety and efficacy of TSO treatment in active left-sided ulcerative colitis and its effects on mucosal immune state and microbiota.</p><div class=\"tiny-share-widget\" data-id=\"733291\" data-linked=\"Coronado Biosciences (CNDO -5.9%) says it&#39;s signed a clinical trial agreement with the National...\" data-tweet=\"$FBIO - Coronado Biosciences (CNDO -5.9%) says it&#39;s signed a clinical trial agreement with the National Institute of Allergy and Infectious Diseases to evaluate its experimental Trichuris suis ova, or CNDO-201, for the treatment of ulcerative colitis. T... https://seekingalpha.com/news/733291?source=tweet\" data-url=\"https://seekingalpha.com/news/733291\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733261\" data-ts=\"1356114737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAR\" target=\"_blank\">DAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733261\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Darling International (DAR -7.4%) slides today after being downgraded at Stephens to Equal...</a></h4><p>Darling International (<a href=\"https://seekingalpha.com/symbol/DAR\" title=\"Darling Ingredients Inc.\">DAR</a> <font color=\"red\">-7.4%</font>) slides today after <a href=\"http://www.streetinsider.com/Downgrades/Stephens+Downgrades+Darling+International+%28DAR%29+to+Equal+Weight/7965893.html\" target=\"_blank\">being downgraded</a> at Stephens to Equal Weight. The firm cites near-term pressure on it's end product pricing. The price target was also lowered to $18 from $19 a share.</p><div class=\"tiny-share-widget\" data-id=\"733261\" data-linked=\"Darling International (DAR -7.4%) slides today after being downgraded at Stephens to Equal...\" data-tweet=\"$DAR - Darling International (DAR -7.4%) slides today after being downgraded at Stephens to Equal Weight. The firm cites near-term pressure on it&#39;s end product pricing. The price target was also lowered to $18 from $19 a share. https://seekingalpha.com/news/733261?source=tweet\" data-url=\"https://seekingalpha.com/news/733261\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733231\" data-ts=\"1356113336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KIT Digital (KITD -52.4%) loses over half its remaining equity value after announcing it has...</a></h4><p>KIT Digital (KITD <font color=\"red\">-52.4%</font>) loses over half its remaining equity value after announcing it has been <a href=\"http://finance.yahoo.com/news/kit-digital-change-auditors-announces-140000108.html\" target=\"_blank\">de-listed by the Nasdaq</a>, and now trades over-the-counter. The company <a href=\"http://biz.yahoo.com/e/121218/kitd8-k.html\" target=\"_blank\">also says</a> it has dismissed independent auditor Grant Thornton, as its audit committee works to restate 2009-2011 results due to \"errors and irregularities\" related to the recognition of perpetual software license revenue (<a href=\"https://seekingalpha.com/currents/post/680181\" target=\"_blank\">previous</a>). A bankruptcy filing may just be a matter of time.</p><div class=\"tiny-share-widget\" data-id=\"733231\" data-linked=\"KIT Digital (KITD -52.4%) loses over half its remaining equity value after announcing it has...\" data-tweet=\"KIT Digital (KITD -52.4%) loses over half its remaining equity value after announcing it has been de-listed by the Nasdaq, and now trades over-the-counter. The company also says it has dismissed independent auditor Grant Thornton, as its audit committee... https://seekingalpha.com/news/733231?source=tweet\" data-url=\"https://seekingalpha.com/news/733231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733201\" data-ts=\"1356112201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron (MU -7.4%) is off sharply in response to its FQ3 miss, which had much to do with an 11%...</a></h4><p>Micron (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"red\">-7.4%</font>) is off sharply in response to its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/731571\">FQ3 miss</a>, which had much to do with <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/731831\">an 11% drop</a> in DRAM ASPs. CLSA has \"downgraded\" shares to Outperform from Buy, but <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Worst+Is+Behind%2C+Buy+Micron+%28MU%29+On+Weakness+-+Analyst/7965985.html\">Wedbush</a> and <a target=\"_blank\" href=\"http://blogs.barrons.com/techtraderdaily/2012/12/21/this-morning-rims-service-strategy-spooks-shares-aapl-notches-u-s-gains/\">Jefferies</a> argue a rebound is due: the latter sees gross margin rising 1500 bps over the next 12 months. SanDisk (SNDK <font color=\"red\">-0.8%</font>) is off just modestly (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/731801\">previous</a>) - Micron noted on its <a target=\"_blank\" href=\"https://seekingalpha.com/article/1076651-micron-technology-management-discusses-q1-2013-results-earnings-call-transcript\">call</a> NAND flash pricing is stable. But DRAM/NAND giant Samsung (<a href=\"https://seekingalpha.com/symbol/SSNLF\" title=\"Samsung Electronics Co., Ltd.\">OTC:SSNLF</a>) <font color=\"red\">fell 4.1%</font> in Seoul. This morning, Micron announced Japanese regulators had signed off on the Elpida deal, as expected.</p><div class=\"tiny-share-widget\" data-id=\"733201\" data-linked=\"Micron (MU -7.4%) is off sharply in response to its FQ3 miss, which had much to do with an 11%...\" data-tweet=\"$MU $MU $WDC - Micron (MU -7.4%) is off sharply in response to its FQ3 miss, which had much to do with an 11% drop in DRAM ASPs. CLSA has &quot;downgraded&quot; shares to Outperform from Buy, but Wedbush and Jefferies argue a rebound is due: the latter sees gross... https://seekingalpha.com/news/733201?source=tweet\" data-url=\"https://seekingalpha.com/news/733201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733181\" data-ts=\"1356111951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: HALO +27%. CEMI +24%. ASCA +20%. FCFC +18%. PNK +17%. ABCD +14%. ATAI...</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/HALO' title='Halozyme Therapeutics, Inc.'>HALO</a> <font color=\"green\">+27%</font>. <a href='https://seekingalpha.com/symbol/CEMI' title='Chembio Diagnostics, Inc.'>CEMI</a> <font color=\"green\">+24%</font>. <a href='https://seekingalpha.com/symbol/ASCA' title='Ameristar Casinos, Inc.'>ASCA</a> <font color=\"green\">+20%</font>. <a href='https://seekingalpha.com/symbol/FCFC' title='FirstCity Financial Corporation'>FCFC</a> <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/PNK' title='Pinnacle Entertainment, Inc.'>PNK</a> <font color=\"green\">+17%</font>. <a href='https://seekingalpha.com/symbol/ABCD' title='Cambium Learning Group, Inc.'>ABCD</a> <font color=\"green\">+14%</font>. <a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a> <font color=\"green\">+12%</font>. <a href='https://seekingalpha.com/symbol/BONA' title='Bona Film Group Limited'>BONA</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/WWAY' title='Westway Group Inc'>WWAY</a> <font color=\"green\">+9%</font>. <a href='https://seekingalpha.com/symbol/IKAN' title='Ikanos Communications, Inc.'>IKAN</a> <font color=\"green\">+9%</font>. <br /><b>Midday top 10 Losers:</b> CT <font color=\"red\">-52%</font>. <a href='https://seekingalpha.com/symbol/ALX' title='Alexanders Inc.'>ALX</a> <font color=\"red\">-26%</font>. RIMM <font color=\"red\">-21%</font>. <a href='https://seekingalpha.com/symbol/EDMC' title='Education Management Corporation'>EDMC</a> <font color=\"red\">-19%</font>. <a href='https://seekingalpha.com/symbol/MSON' title='MISONIX, Inc.'>MSON</a> <font color=\"red\">-17%</font>. <a href='https://seekingalpha.com/symbol/ECTE' title='Echo Therapeutics'>OTC:ECTE</a> <font color=\"red\">-17%</font>. <a href='https://seekingalpha.com/symbol/HLF' title='Herbalife Ltd.'>HLF</a> <font color=\"red\">-14%</font>. OPXA <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/MHH' title='Mastech Digital, Inc.'>MHH</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/AMPL' title='Ampal - American Israel Corporation'>AMPL</a> <font color=\"red\">-11%</font>.<div class=\"tiny-share-widget\" data-id=\"733181\" data-linked=\"Midday top 10 gainers: HALO +27%. CEMI +24%. ASCA +20%. FCFC +18%. PNK +17%. ABCD +14%. ATAI...\" data-tweet=\"$HALO $HALO $CEMI - Midday top 10 gainers: HALO +27%. CEMI +24%. ASCA +20%. FCFC +18%. PNK +17%. ABCD +14%. ATAI +12%. BONA +11%. WWAY +9%. IKAN +9%. Midday top 10 Losers: CT -52%. ALX -26%. RIMM -21%. EDMC -19%. MSON -17%. OTC:ECTE -17%. HLF -14%. OPXA... https://seekingalpha.com/news/733181?source=tweet\" data-url=\"https://seekingalpha.com/news/733181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733161\" data-ts=\"1356111796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECTE\" target=\"_blank\">ECTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733161\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Echo Therapeutics (OTC:ECTE -17%) trades lower today after the company priced its previously...</a></h4><p>Echo Therapeutics (<a href=\"https://seekingalpha.com/symbol/ECTE\" title=\"Echo Therapeutics\">OTC:ECTE</a> <font color=\"red\">-17%</font>) trades lower today after the company priced its previously announced 3.2M secondary offering at $0.95 per share, an 18% discount to yesterday's close. Aegis Capital is the sole book-running manager for the offering.</p><div class=\"tiny-share-widget\" data-id=\"733161\" data-linked=\"Echo Therapeutics (OTC:ECTE -17%) trades lower today after the company priced its previously...\" data-tweet=\"$ECTE - Echo Therapeutics (OTC:ECTE -17%) trades lower today after the company priced its previously announced 3.2M secondary offering at $0.95 per share, an 18% discount to yesterday&#39;s close. Aegis Capital is the sole book-running manager for the offer... https://seekingalpha.com/news/733161?source=tweet\" data-url=\"https://seekingalpha.com/news/733161\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733091\" data-ts=\"1356110131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Online travel stocks are underperforming on a day when Expedia (EXPE -2.2%) announced it&#39;s...</a></h4><p>Online travel stocks are underperforming on a day when Expedia (<a href=\"https://seekingalpha.com/symbol/EXPE\" title=\"Expedia, Inc.\">EXPE</a> <font color=\"red\">-2.2%</font>) announced it's <a href=\"https://seekingalpha.com/currents/post/732841\" target=\"_blank\">buying 61%</a> of popular German hotel bookings site Trivago. PCLN <font color=\"red\">-2.4%</font>. <a href=\"https://seekingalpha.com/symbol/TRIP\" title=\"TripAdvisor Inc.\">TRIP</a> <font color=\"red\">-2.7%</font>. <a href=\"https://seekingalpha.com/symbol/OWW\" title=\"Orbitz Worldwide, Inc.\">OWW</a> <font color=\"red\">-4.6%</font>. <a href=\"https://seekingalpha.com/symbol/TZOO\" title=\"Travelzoo Inc\">TZOO</a> <font color=\"red\">-3.3%</font>. Priceline received 83% of its Q3 gross bookings from international markets, and the bulk of that came from Europe.</p><div class=\"tiny-share-widget\" data-id=\"733091\" data-linked=\"Online travel stocks are underperforming on a day when Expedia (EXPE -2.2%) announced it&#39;s...\" data-tweet=\"$EXPE $EXPE $BKNG - Online travel stocks are underperforming on a day when Expedia (EXPE -2.2%) announced it&#39;s buying 61% of popular German hotel bookings site Trivago. PCLN -2.4%. TRIP -2.7%. OWW -4.6%. TZOO -3.3%. Priceline received 83% of its Q3 gros... https://seekingalpha.com/news/733091?source=tweet\" data-url=\"https://seekingalpha.com/news/733091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733081\" data-ts=\"1356109712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIBX\" target=\"_blank\">TIBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tibco&amp;nbsp; (TIBX +6.3%) and Red Hat (RHT +3.8%) are continuing their post-earnings rallies,...</a></h4><p>Tibco  (<a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a> <font color=\"green\">+6.3%</font>) and Red Hat (<a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a> <font color=\"green\">+3.8%</font>) are continuing their post-earnings rallies, even as Goldman airs cautious comments (<a href=\"http://www.streetinsider.com/Analyst+Comments/Tibco+%28TIBX%29+Has+Execution+Issues%2C+Says+Goldman/7966118.html\" target=\"_blank\">I</a>, <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Goldman+Maintains+Neutral+On+Red+Hat+%28RHT%29%2C+Waiting+On+Accelerated+Billings+Growth/7965871.html\" target=\"_blank\">II</a>) on each. In light of its <a href=\"https://seekingalpha.com/currents/post/700101\" target=\"_blank\">Dec. 4 warning</a>, the firm seem Tibco hampered by execution problems related to Americas sales, process control, and an understaffed management, and thinks needed investments will depress margins. Goldman likes Red Hat's product line, but doesn't think shares deserve a Buy rating until organic billings growth gets back above 20%. (<a href=\"https://seekingalpha.com/currents/post/731781\" target=\"_blank\">Tibco FQ4</a>) (Red Hat FQ3: <a href=\"https://seekingalpha.com/currents/post/731541\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/731701\" target=\"_blank\">II</a>, <a href=\"https://seekingalpha.com/currents/post/731881\" target=\"_blank\">III</a>) (transcripts: <a href=\"https://seekingalpha.com/article/1076561-tibco-software-management-discusses-q4-2012-results-earnings-call-transcript\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/article/1076571-red-hat-management-discusses-q3-2013-results-earnings-call-transcript\" target=\"_blank\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"733081\" data-linked=\"Tibco  (TIBX +6.3%) and Red Hat (RHT +3.8%) are continuing their post-earnings rallies, even as...\" data-tweet=\"$TIBX $TIBX $RHT - Tibco  (TIBX +6.3%) and Red Hat (RHT +3.8%) are continuing their post-earnings rallies, even as Goldman airs cautious comments (I, II) on each. In light of its Dec. 4 warning, the firm seem Tibco hampered by execution problems related... https://seekingalpha.com/news/733081?source=tweet\" data-url=\"https://seekingalpha.com/news/733081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733071\" data-ts=\"1356109324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMI\" target=\"_blank\">CEMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733071\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chembio Diagnostics (CEMI +25%) ramps up after getting the FDA stamp of approval to market it&#39;s...</a></h4><p>Chembio Diagnostics (<a href=\"https://seekingalpha.com/symbol/CEMI\" title=\"Chembio Diagnostics, Inc.\">CEMI</a> <font color=\"green\">+25%</font>) ramps up after getting the FDA stamp of approval to market it's Dual Path Platform HIV 1/2 assay for the rapid, point-of-care detection of HIV-1/2 antibodies in either oral fluid or blood samples. The platform has been found to be more accurate compared with the current comparable HIV test technologies.</p><div class=\"tiny-share-widget\" data-id=\"733071\" data-linked=\"Chembio Diagnostics (CEMI +25%) ramps up after getting the FDA stamp of approval to market it&#39;s...\" data-tweet=\"$CEMI - Chembio Diagnostics (CEMI +25%) ramps up after getting the FDA stamp of approval to market it&#39;s Dual Path Platform HIV 1/2 assay for the rapid, point-of-care detection of HIV-1/2 antibodies in either oral fluid or blood samples. The platform has... https://seekingalpha.com/news/733071?source=tweet\" data-url=\"https://seekingalpha.com/news/733071\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733041\" data-ts=\"1356109140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil&amp;rsquo;s government go-ahead for Petrobras (PBR -3.6%) to raise its gasoline prices in...</a></h4><p>Brazil\u2019s government go-ahead for Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petrobras - Petroleo Brasileiro S.A.\">PBR</a> <font color=\"red\">-3.6%</font>) to <a target=\"_blank\" href=\"http://blogs.wsj.com/marketbeat/2012/12/21/brazilian-gas-price-hike-sweetens-outlook-for-ethanol/\">raise its gasoline prices</a> in early 2013 likely will raise demand for domestically produced sugar-based ethanol, but effects also could reach U.S. shores. Ethanol output in the U.S. is expected fall ~10% next year, and a robust export market could give Brazilian mills even more incentive to produce ethanol instead of sugar.</p><div class=\"tiny-share-widget\" data-id=\"733041\" data-linked=\"Brazil\u2019s government go-ahead for Petrobras (PBR -3.6%) to raise its gasoline prices in early...\" data-tweet=\"$PBR $CORN $JJGTF - Brazil\u2019s government go-ahead for Petrobras (PBR -3.6%) to raise its gasoline prices in early 2013 likely will raise demand for domestically produced sugar-based ethanol, but effects also could reach U.S. shores. Ethanol output in the... https://seekingalpha.com/news/733041?source=tweet\" data-url=\"https://seekingalpha.com/news/733041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"733011\" data-ts=\"1356108219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/733011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell Energy (FCEL -3.5%) shares stumble after the power equipment maker reported widening...</a></h4><p>FuelCell Energy (<a href=\"https://seekingalpha.com/symbol/FCEL\" title=\"FuelCell Energy, Inc.\">FCEL</a> <font color=\"red\">-3.5%</font>) shares stumble after the power equipment maker reported <a href=\"https://seekingalpha.com/currents/post/731981\" target=\"_blank\">widening losses</a> in FQ4 as expenses grew, masking modest revenue growth. FCEL also acquired the 61% of shares it didn't already own in Versa Power Systems, a solid oxide fuel cell developer, in a deal valued at ~$3.3M.</p><div class=\"tiny-share-widget\" data-id=\"733011\" data-linked=\"FuelCell Energy (FCEL -3.5%) shares stumble after the power equipment maker reported widening...\" data-tweet=\"$FCEL - FuelCell Energy (FCEL -3.5%) shares stumble after the power equipment maker reported widening losses in FQ4 as expenses grew, masking modest revenue growth. FCEL also acquired the 61% of shares it didn&#39;t already own in Versa Power Systems, a sol... https://seekingalpha.com/news/733011?source=tweet\" data-url=\"https://seekingalpha.com/news/733011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732991\" data-ts=\"1356108058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halozyme Therapeutics (NASDAQ:HALO) is soaring over 27.6% on the back of the company&#39;s...</a></h4><p>Halozyme Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a>) is soaring over <font color=\"green\">27.6%</font> on the back of the company's pre-market announcement that it had entered into a <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/732241\">worldwide license agreement</a> with Pfizer (<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a> <font color=\"red\">-1.1%</font>).</p><div class=\"tiny-share-widget\" data-id=\"732991\" data-linked=\"Halozyme Therapeutics (NASDAQ:HALO) is soaring over 27.6% on the back of the company&#39;s...\" data-tweet=\"$HALO $HALO $PFE - Halozyme Therapeutics (NASDAQ:HALO) is soaring over 27.6% on the back of the company&#39;s pre-market announcement that it had entered into a worldwide license agreement with Pfizer (PFE -1.1%). https://seekingalpha.com/news/732991?source=tweet\" data-url=\"https://seekingalpha.com/news/732991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732971\" data-ts=\"1356107519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford (WFT -2.2%) shares drop as Barclays cuts its Q4 and 2013 expectations for the...</a></h4>Weatherford (<a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color=\"red\">-2.2%</font>) shares drop as Barclays <a href=\"http://www.marketwatch.com/story/energy-stocks-decline-anadarko-down-15-2012-12-21\" target=\"_blank\">cuts its Q4 and 2013  expectations</a> for the oilfield services company, saying it has been affected by slowdowns in North America, and smaller margins and revenues in its Latin America  business. The firm expects Q4 EPS of $0.16 vs. $0.19 analyst consensus estimate.<div class=\"tiny-share-widget\" data-id=\"732971\" data-linked=\"Weatherford (WFT -2.2%) shares drop as Barclays cuts its Q4 and 2013 expectations for the...\" data-tweet=\"$WFT $WFTIQ - Weatherford (WFT -2.2%) shares drop as Barclays cuts its Q4 and 2013 expectations for the oilfield services company, saying it has been affected by slowdowns in North America, and smaller margins and revenues in its Latin America business.... https://seekingalpha.com/news/732971?source=tweet\" data-url=\"https://seekingalpha.com/news/732971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732961\" data-ts=\"1356107505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Venaxis, formerly AspenBio Pharma (APPY +2.3) has filed for CE Mark approval in Europe for...</a></h4><p>Venaxis, formerly AspenBio Pharma (APPY +2.3) has <a href=\"http://www.streetinsider.com/Corporate+News/Venaxis+%28APPY%29+Files+fo+CE+Mark+Approval+on+Appendicitis+Test+APPY1/7965848.html\" target=\"_blank\">filed for CE Mark approval</a> in Europe for APPY1, a blood-based appendicitis test. The drug developer expects to obtain approval by the end of the year. Initial commercialization in Europe is planned for the Q113 in key European territories, including the UK, Italy, France, Germany and Belgium.</p><div class=\"tiny-share-widget\" data-id=\"732961\" data-linked=\"Venaxis, formerly AspenBio Pharma (APPY +2.3) has filed for CE Mark approval in Europe for...\" data-tweet=\"Venaxis, formerly AspenBio Pharma (APPY +2.3) has filed for CE Mark approval in Europe for APPY1, a blood-based appendicitis test. The drug developer expects to obtain approval by the end of the year. Initial commercialization in Europe is planned for t... https://seekingalpha.com/news/732961?source=tweet\" data-url=\"https://seekingalpha.com/news/732961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732751\" data-ts=\"1356103228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKT\" target=\"_blank\">PKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Procera (PKT +2.7%) trades higher on a down day after getting added to the S&amp;amp;P SmallCap 600....</a></h4><p>Procera (<a href=\"https://seekingalpha.com/symbol/PKT\" title=\"Procera Networks, Inc\">PKT</a> <font color=\"green\">+2.7%</font>) trades higher on a down day after getting added to the S&amp;P SmallCap 600. Procera is replacing insurance holding firm Presidential Life, which is getting acquired by Athene Holding. (PR) (<a href=\"https://seekingalpha.com/currents/post/725651\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"732751\" data-linked=\"Procera (PKT +2.7%) trades higher on a down day after getting added to the S&amp;amp;P SmallCap 600....\" data-tweet=\"$PKT - Procera (PKT +2.7%) trades higher on a down day after getting added to the S&amp;P SmallCap 600. Procera is replacing insurance holding firm Presidential Life, which is getting acquired by Athene Holding. (PR) (previous) https://seekingalpha.com/news/732751?source=tweet\" data-url=\"https://seekingalpha.com/news/732751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732681\" data-ts=\"1356102089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMSC\" target=\"_blank\">AMSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Superconductor (AMSC -4.4%) slips after disclosing it&#39;s allowing Capital Ventures,...</a></h4><p>American Superconductor (<a href=\"https://seekingalpha.com/symbol/AMSC\" title=\"American Superconductor Corporation\">AMSC</a> <font color=\"red\">-4.4%</font>) slips after <a href=\"http://biz.yahoo.com/e/121221/amsc8-k.html\" target=\"_blank\">disclosing</a> it's allowing Capital Ventures, which provided the company with needed funds earlier this year, to exchange a regular note for a convertible note. It's also allowing Capital to own up to 9.99% of AMSC, up from a prior 4.99%. (<a href=\"https://seekingalpha.com/currents/post/565291\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"732681\" data-linked=\"American Superconductor (AMSC -4.4%) slips after disclosing it&#39;s allowing Capital Ventures,...\" data-tweet=\"$AMSC - American Superconductor (AMSC -4.4%) slips after disclosing it&#39;s allowing Capital Ventures, which provided the company with needed funds earlier this year, to exchange a regular note for a convertible note. It&#39;s also allowing Capital to own up t... https://seekingalpha.com/news/732681?source=tweet\" data-url=\"https://seekingalpha.com/news/732681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732631\" data-ts=\"1356101532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNRA\" target=\"_blank\">PNRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732631\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Panera Bread (PNRA -2.6%) trades lower with&amp;nbsp; buzz circulating around that negative comments...</a></h4>Panera Bread (<a href='https://seekingalpha.com/symbol/PNRA' title='Panera Bread Company'>PNRA</a> <font color=\"red\">-2.6%</font>) trades lower with&nbsp; <a target=\"_blank\" href=\"https://twitter.com/markflowchatter/status/282131187596656641\">buzz</a> circulating around that negative comments from ITG Majestic are hurting sentiment. The investment firm warns the restaurant operator could miss sales estimates, a rather tricky wicket for Panera with valuation stretched.<div class=\"tiny-share-widget\" data-id=\"732631\" data-linked=\"Panera Bread (PNRA -2.6%) trades lower with&amp;nbsp; buzz circulating around that negative comments...\" data-tweet=\"$PNRA - Panera Bread (PNRA -2.6%) trades lower with&amp;nbsp; buzz circulating around that negative comments from ITG Majestic are hurting sentiment. The investment firm warns the restaurant operator could miss sales estimates, a rather tricky wicket for Pa... https://seekingalpha.com/news/732631?source=tweet\" data-url=\"https://seekingalpha.com/news/732631\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732611\" data-ts=\"1356101084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMY\" target=\"_blank\">HMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732611\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Labor disruptions that paralyzed South Africa&#39;s mining sector earlier this year are resurfacing,...</a></h4>Labor disruptions that paralyzed South Africa's mining sector earlier this year are resurfacing, as Harmony Gold (<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color=\"red\">-2.6%</font>) says ~1,700 employees <a target=\"_blank\" href=\"http://www.marketwatch.com/story/harmony-gold-1700-staff-wont-come-to-surface-2012-12-21\">refused to come up</a> from underground at its Kusasalethu mine, demanding the reinstatement of suspended colleagues. The mine had been <a href=\"https://seekingalpha.com/currents/post/730471\" target=\"_blank\">closed</a> after clashes resulted in shots being fired and damage to mine equipment.<div class=\"tiny-share-widget\" data-id=\"732611\" data-linked=\"Labor disruptions that paralyzed South Africa&#39;s mining sector earlier this year are resurfacing,...\" data-tweet=\"$HMY - Labor disruptions that paralyzed South Africa&#39;s mining sector earlier this year are resurfacing, as Harmony Gold (HMY -2.6%) says ~1,700 employees refused to come up from underground at its Kusasalethu mine, demanding the reinstatement of suspend... https://seekingalpha.com/news/732611?source=tweet\" data-url=\"https://seekingalpha.com/news/732611\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732551\" data-ts=\"1356100095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RIM (RIMM) may have agreed to eliminate fees for consumer services in exchange for BB10 purchase...</a></h4><p>RIM (RIMM) may have <a href=\"http://www.forbes.com/sites/ericsavitz/2012/12/21/rim-shocks-investors-with-revised-services-strategy/\" target=\"_blank\">agreed to eliminate</a> fees for consumer services in exchange for BB10 purchase commitments from carriers, thinks Jefferies' Peter Misek, citing build plan checks and management's unwillingness to talk about consumer revenue during RIM's <a href=\"https://seekingalpha.com/article/1076641-research-in-motion-limited-management-discusses-q3-2013-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call</a>. Enterprises who want advanced security/management features will pay the normal rate, but Thorsten Heins admitted many smaller businesses are unlikely to buy. Citi notes services account for about 3/4 of gross profits. Shares <font color=\"red\">-16.4%</font>. (FQ3: <a href=\"https://seekingalpha.com/currents/post/731581\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/731611\" target=\"_blank\">II</a>, <a href=\"https://seekingalpha.com/currents/post/731911\" target=\"_blank\">III</a>)</p><div class=\"tiny-share-widget\" data-id=\"732551\" data-linked=\"RIM (RIMM) may have agreed to eliminate fees for consumer services in exchange for BB10 purchase...\" data-tweet=\"$BB - RIM (RIMM) may have agreed to eliminate fees for consumer services in exchange for BB10 purchase commitments from carriers, thinks Jefferies&#39; Peter Misek, citing build plan checks and management&#39;s unwillingness to talk about consumer revenue durin... https://seekingalpha.com/news/732551?source=tweet\" data-url=\"https://seekingalpha.com/news/732551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732481\" data-ts=\"1356099040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.Losers:...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/CEMI\" title=\"Chembio Diagnostics, Inc.\">CEMI</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/ASCA\" title=\"Ameristar Casinos, Inc.\">ASCA</a> <font color=\"green\">+17%</font>. APPY <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/PNK\" title=\"Pinnacle Entertainment, Inc.\">PNK</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/SHP\" title=\"ShangPharma Corporation\">SHP</a> <font color=\"green\">+5%</font>.<br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ECTE\" title=\"Echo Therapeutics\">OTC:ECTE</a> <font color=\"red\">-18%</font>. RIMM <font color=\"red\">-14%</font>. ALU <font color=\"red\">-7%</font>.<div class=\"tiny-share-widget\" data-id=\"732481\" data-linked=\"Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.Losers:...\" data-tweet=\"$HALO $HALO $CEMI - Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.Losers: OTC:ECTE -18%. RIMM -14%. ALU -7%. https://seekingalpha.com/news/732481?source=tweet\" data-url=\"https://seekingalpha.com/news/732481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732471\" data-ts=\"1356099001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcatel-Lucent (ALU) -6.9% after S&amp;amp;P lowers its outlook to Negative, while affirming its &#39;B&#39;...</a></h4><p>Alcatel-Lucent (ALU) <font color=\"red\">-6.9%</font> after <a href=\"http://www.streetinsider.com/Credit+Ratings/UPDATE%3A+S%26P+Revises+Outlook+on+Alcatel-Lucent+%28ALU%29+to+Negative/7965986.html\" target=\"_blank\">S&amp;P lowers its outlook</a> to Negative, while affirming its 'B' rating on the company's debt. The agency says its base-case scenario now assumes weaker revenue, margins, and operating cash flow for 2012 and 2013 than previously, though it still expects positive revenue growth and operating margins next year. Sell-side analysts <a href=\"http://finance.yahoo.com/q/ae?s=ALU+Analyst+Estimates\" target=\"_blank\">aren't so sure</a> about that. Alcatel shares have been <a href=\"https://seekingalpha.com/currents/post/729091\" target=\"_blank\">on a tear </a>over the last week, since its <a href=\"https://seekingalpha.com/currents/post/720021\" target=\"_blank\">financing deal</a> was announced.</p><div class=\"tiny-share-widget\" data-id=\"732471\" data-linked=\"Alcatel-Lucent (ALU) -6.9% after S&amp;amp;P lowers its outlook to Negative, while affirming its &#39;B&#39;...\" data-tweet=\"$NOK - Alcatel-Lucent (ALU) -6.9% after S&amp;P lowers its outlook to Negative, while affirming its &#39;B&#39; rating on the company&#39;s debt. The agency says its base-case scenario now assumes weaker revenue, margins, and operating cash flow for 2012 and 2013 than ... https://seekingalpha.com/news/732471?source=tweet\" data-url=\"https://seekingalpha.com/news/732471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732451\" data-ts=\"1356098499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMCR\" target=\"_blank\">GMCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Green Mountain Coffee Roasters (NASDAQ:GMCR) trail off 3.5% premarket without any...</a></h4><p>Shares of Green Mountain Coffee Roasters (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GMCR\" title=\"Keurig Green Mountain Inc\">GMCR</a>) <font color=\"red\">trail off 3.5%</font> premarket without any company news of note out. Traders warn a risk-off mentality could hurt the stock (more than others) until the end of the year, while SA author Bill Maurer <a href=\"https://seekingalpha.com/article/1076421-is-green-mountain-an-attractive-takeover-target\" target=\"_blank\">wonders</a> what the impact will be of the company' slashed guidance for capital expenditure spending.</p><div class=\"tiny-share-widget\" data-id=\"732451\" data-linked=\"Shares of Green Mountain Coffee Roasters (NASDAQ:GMCR) trail off 3.5% premarket without any...\" data-tweet=\"$GMCR - Shares of Green Mountain Coffee Roasters (NASDAQ:GMCR) trail off 3.5% premarket without any company news of note out. Traders warn a risk-off mentality could hurt the stock (more than others) until the end of the year, while SA author Bill Maure... https://seekingalpha.com/news/732451?source=tweet\" data-url=\"https://seekingalpha.com/news/732451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732441\" data-ts=\"1356098302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTI\" target=\"_blank\">NTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732441\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Tier Energy (NYSE:NTI) CEO Mario Rodriguez resigns effective immediately and will be...</a></h4><p>Northern Tier Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/NTI\" title=\"Northern Tier Energy\">NTI</a>) CEO Mario Rodriguez resigns effective immediately and will be replaced by President and COO Hank Kuchta. NTI reaffirms Q4 operational guidance, forecasting total throughput of 80K-85K bbl/day. NTI <font color=\"red\">-2.5%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"732441\" data-linked=\"Northern Tier Energy (NYSE:NTI) CEO Mario Rodriguez resigns effective immediately and will be...\" data-tweet=\"$NTI - Northern Tier Energy (NYSE:NTI) CEO Mario Rodriguez resigns effective immediately and will be replaced by President and COO Hank Kuchta. NTI reaffirms Q4 operational guidance, forecasting total throughput of 80K-85K bbl/day. NTI -2.5% premarket. https://seekingalpha.com/news/732441?source=tweet\" data-url=\"https://seekingalpha.com/news/732441\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732271\" data-ts=\"1356094982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal (NYSE:MT) takes a $4.3B writedown on the value of its struggling European division...</a></h4><p>ArcelorMittal (NYSE:<a href=\"https://seekingalpha.com/symbol/MT\" title=\"ArcelorMittal\">MT</a>) <a target=\"_blank\" href=\"http://finance.yahoo.com/news/arcelormittal-record-non-cash-impairment-070401430.html\">takes a $4.3B writedown</a> on the value of its struggling European division and says it sees little prospect for an improvement in the region's sluggish economy any time soon. MT says steel demand in Europe fell 8% this year and the cumulative demand decline over the past five years is 29%. MT <font color=\"red\">-3.2%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"732271\" data-linked=\"ArcelorMittal (NYSE:MT) takes a $4.3B writedown on the value of its struggling European division...\" data-tweet=\"$MT - ArcelorMittal (NYSE:MT) takes a $4.3B writedown on the value of its struggling European division and says it sees little prospect for an improvement in the region&#39;s sluggish economy any time soon. MT says steel demand in Europe fell 8% this year a... https://seekingalpha.com/news/732271?source=tweet\" data-url=\"https://seekingalpha.com/news/732271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732231\" data-ts=\"1356093559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Walgreen (WAG): Prescription sales fell 7.2% compared to a year ago while generic...</a></h4><p>More on Walgreen (WAG): Prescription sales fell 7.2% compared to a year ago while generic introductions negatively impacted sales by 4.9 percentage points in the quarter. Overall, total sales in comparable stores declined a disappointing 8%. The company opened 218 new drugstores during the period. WAG <font color=\"red\">-2.2%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"732231\" data-linked=\"More on Walgreen (WAG): Prescription sales fell 7.2% compared to a year ago while generic...\" data-tweet=\"$WBA - More on Walgreen (WAG): Prescription sales fell 7.2% compared to a year ago while generic introductions negatively impacted sales by 4.9 percentage points in the quarter. Overall, total sales in comparable stores declined a disappointing 8%. The ... https://seekingalpha.com/news/732231?source=tweet\" data-url=\"https://seekingalpha.com/news/732231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732221\" data-ts=\"1356093555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTK\" target=\"_blank\">PRTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transcept Pharmaceuticals (TSPT) announces poor results in Phase 2 testing of its TO-2061 pills...</a></h4><p>Transcept Pharmaceuticals (TSPT) announces poor results in Phase 2 testing of its TO-2061 pills in patients with OCD. Shares remain halted. <strong>Update at 9:10 ET</strong>: Shares are <font color=\"red\">off 14.7%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"732221\" data-linked=\"Transcept Pharmaceuticals (TSPT) announces poor results in Phase 2 testing of its TO-2061 pills...\" data-tweet=\"$PRTK - Transcept Pharmaceuticals (TSPT) announces poor results in Phase 2 testing of its TO-2061 pills in patients with OCD. Shares remain halted. Update at 9:10 ET: Shares are off 14.7% premarket. (PR) https://seekingalpha.com/news/732221?source=tweet\" data-url=\"https://seekingalpha.com/news/732221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"732171\" data-ts=\"1356092833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASCA\" target=\"_blank\">ASCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/732171\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ameristar Casinos (NASDAQ:ASCA) is gobbled up by Pinnacle Entertainment (NASDAQ:PNK) for...</a></h4><p>Ameristar Casinos (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ASCA\" title=\"Ameristar Casinos, Inc.\">ASCA</a>) is gobbled up by Pinnacle Entertainment (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PNK\" title=\"Pinnacle Entertainment, Inc.\">PNK</a>) for $26.50/share, giving the company a total enterprise value of $2.8B. ASCA shares closed at $22.07 last night. Might Boyd Gaming (NYSE:<a href=\"https://seekingalpha.com/symbol/BYD\" title=\"Boyd Gaming Corporation\">BYD</a>) be on someone's shopping list? (PR)</p><div class=\"tiny-share-widget\" data-id=\"732171\" data-linked=\"Ameristar Casinos (NASDAQ:ASCA) is gobbled up by Pinnacle Entertainment (NASDAQ:PNK) for...\" data-tweet=\"$ASCA $ASCA $PNK - Ameristar Casinos (NASDAQ:ASCA) is gobbled up by Pinnacle Entertainment (NASDAQ:PNK) for $26.50/share, giving the company a total enterprise value of $2.8B. ASCA shares closed at $22.07 last night. Might Boyd Gaming (NYSE:BYD) be on s... https://seekingalpha.com/news/732171?source=tweet\" data-url=\"https://seekingalpha.com/news/732171\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li>","count":39,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}